Microshell Enhanced Acoustic Adjuvants for Immunotherapy in Glioblastoma
نویسندگان
چکیده
منابع مشابه
Adjuvants for immunotherapy: lost in translation?
Allergen-specific immunotherapy (SIT) has been used for the treatment of allergic diseases since it was first applied by Noon in 1911 [1]. Ever since, not much has changed in the original treatment protocol of subcutaneous injections with increasing doses of crude allergen extracts. This seems rather surprising because it is currently the only disease modifying treatment that offers long-term p...
متن کاملImmunotherapy for Glioblastoma
Glioblastoma (GBM) is the most common primary malignant brain cancer with a dismal prognosis in spite of aggressive treatment options. Although once thought to be an “immune-privileged” site, recent advances have begun to highlight the complex interaction between the immune system and the central nervous system. Thus, great interest has emerged in the ability of immunotherapy to potentially pro...
متن کاملAdvances in Immunotherapy for Glioblastoma Multiforme
Glioblastoma multiforme (GBM) is the most common primary malignant brain tumor in adults. Patients with GBM have poor outcomes, even with the current gold-standard first-line treatment: maximal safe resection combined with radiotherapy and temozolomide chemotherapy. Accumulating evidence suggests that advances in antigen-specific cancer vaccines and immune checkpoint blockade in other advanced ...
متن کاملSelection of Adjuvants for Enhanced Vaccine Potency
The advent of mass vaccination has saved millions of human lives and revolutionized the quality of life. Vaccination is currently one of the most cost effective ways of managing healthcare costs in both emerging and developed countries. Despite the long vaccine history and success, design and development of efficacious and safe vaccines has been traditionally semi-empirical. This is mainly due ...
متن کاملImmunotherapy of glioblastoma multiforme.
Glioblastoma multiforme is immunogenic and several glioblastoma multiforme-related antigens have now been identified. In addition, the immunologic characteristics of the tumor microenvironment that may affect tumor growth are becoming increasingly understood. The type of immune-based approach selected to treat glioblastoma multiforme will depend on the tumor burden. For minimal disease states, ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Advanced Therapeutics
سال: 2019
ISSN: 2366-3987,2366-3987
DOI: 10.1002/adtp.201900066